Does Kewaunee Scientific Corporation have an economic moat?

Based on its FY2026 SEC filings, the Moat Index scores Kewaunee Scientific Corporation (KEQU) 42.7 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 9, returns on capital 51, balance-sheet safety 55, capital discipline 69.

Is KEQU stock trading below its intrinsic value?

Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $46.38 per share versus a recent price of $38.11 — 18% below value. This is an educational estimate computed from primary SEC filings, not investment advice.

How has KEQU's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 42.7 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

Kewaunee Scientific Corporation

KEQU · Healthcare · $109.2M mkt cap · FY2026 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power9

Median gross margin 18.2% over 10y, variable.

Returns on capital51

Median ROIC 12.0%, above the 9% hurdle in 60% of years.

Balance-sheet safety55

Net debt/EBITDA 0.4x, interest coverage 4x.

Capital discipline69

Owner earnings +22.7%/yr, share count growing (dilution).

Margin of safety

Above valueOn sale

18% below value

Owner earnings (normalized): $12.0M
Est. intrinsic value / share: $46.38
Recent price: $38.11
Discount to value: 18% below value

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for KEQU yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale42.7 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — KEQU has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#207 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#205SSKN STRATA SKIN SCIENCES, INC.43.0 out of 100, Shallow moatShallow moat
#206AVTX Avalo Therapeutics, Inc.42.9 out of 100, Shallow moatShallow moat
#208ESMC Escalon Medical Corp.42.6 out of 100, Shallow moatShallow moat
#209VERU VERU INC.42.6 out of 100, Shallow moatShallow moat

Compare KEQU with its nearest peers →All Healthcare companies on the Index →

Common questions about KEQU

Does Kewaunee Scientific Corporation have an economic moat?: Based on its FY2026 SEC filings, the Moat Index scores Kewaunee Scientific Corporation (KEQU) 42.7 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 9, returns on capital 51, balance-sheet safety 55, capital discipline 69.
Is KEQU stock trading below its intrinsic value?: Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $46.38 per share versus a recent price of $38.11 — 18% below value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has KEQU's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 42.7 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows KEQU’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/KEQU"
  width="340" height="150" style="border:0"
  title="KEQU Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell KEQU. See the disclaimer.